Metformin Clinical Trial in HPV+ and HPV– Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate

Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial complex I and oxidative phosphorylation has been reported to correlate with improved outcomes in head and neck squamous cell carcinoma (HNSCC) and other cancers. This effect is postulated to occur through disruption...

Descripción completa

Detalles Bibliográficos
Autores principales: Curry, Joseph M., Johnson, Jennifer, Mollaee, Mehri, Tassone, Patrick, Amin, Dev, Knops, Alexander, Whitaker-Menezes, Diana, Mahoney, My G., South, Andrew, Rodeck, Ulrich, Zhan, Tingting, Harshyne, Larry, Philp, Nancy, Luginbuhl, Adam, Cognetti, David, Tuluc, Madalina, Martinez-Outschoorn, Ubaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193523/
https://www.ncbi.nlm.nih.gov/pubmed/30364350
http://dx.doi.org/10.3389/fonc.2018.00436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193523/
https://www.ncbi.nlm.nih.gov/pubmed/30364350
http://dx.doi.org/10.3389/fonc.2018.00436

Ejemplares similares